Frontiers in Genetics (May 2022)

StarGazer: A Hybrid Intelligence Platform for Drug Target Prioritization and Digital Drug Repositioning Using Streamlit

  • Chiyun Lee,
  • Junxia Lin,
  • Andrzej Prokop,
  • Vancheswaran Gopalakrishnan,
  • Richard N. Hanna,
  • Eliseo Papa,
  • Adrian Freeman,
  • Saleha Patel,
  • Wen Yu,
  • Monika Huhn,
  • Abdul-Saboor Sheikh,
  • Keith Tan,
  • Bret R. Sellman,
  • Taylor Cohen,
  • Jonathan Mangion,
  • Faisal M. Khan,
  • Yuriy Gusev,
  • Khader Shameer

DOI
https://doi.org/10.3389/fgene.2022.868015
Journal volume & issue
Vol. 13

Abstract

Read online

Target prioritization is essential for drug discovery and repositioning. Applying computational methods to analyze and process multi-omics data to find new drug targets is a practical approach for achieving this. Despite an increasing number of methods for generating datasets such as genomics, phenomics, and proteomics, attempts to integrate and mine such datasets remain limited in scope. Developing hybrid intelligence solutions that combine human intelligence in the scientific domain and disease biology with the ability to mine multiple databases simultaneously may help augment drug target discovery and identify novel drug-indication associations. We believe that integrating different data sources using a singular numerical scoring system in a hybrid intelligent framework could help to bridge these different omics layers and facilitate rapid drug target prioritization for studies in drug discovery, development or repositioning. Herein, we describe our prototype of the StarGazer pipeline which combines multi-source, multi-omics data with a novel target prioritization scoring system in an interactive Python-based Streamlit dashboard. StarGazer displays target prioritization scores for genes associated with 1844 phenotypic traits, and is available via https://github.com/AstraZeneca/StarGazer.

Keywords